✦ LIBER ✦

Influence of M-BCR breakpoint sites on the duration of chronic phase in 100 patients with chronic myelocytic leukemia

✍ Scribed by Kimio Tanaka; Tetsuo Hashimoto; Nobuo Oguma; Hiroo Dohy; Nanao Kamada

Book ID: 119105861
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 784 KB
Volume: 70
Category: Article
ISSN: 0165-4608
DOI: 10.1016/0165-4608(93)90129-a

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The position of the M-BCR breakpoint doe

The position of the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukaemia

✍ Jerome Jaubert; Philippe Martiat; Charles Dowding; Norbert Ifrah; John M. Goldma 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Location of breakpoints within the major

Location of breakpoints within the major breakpoint cluster region (bcr) in 33 patients with bcr rearrangement-positive chronic myeloid leukemia (CML) with complex or absent Philadelphia chromosomes

✍ Dr. Ian Dubé; Julie Dixon; Teresa Beckett; Abraham Grossman; Martha Weinstein; P 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 460 KB

We report the sublocalization of the breakpoint in chromosome 22 in 33 patients with chronic myeloid leukemia (CML) who also had unusual marrow cytogenetics. In 23 patients, the leukemic clones were characterized by Philadelphia (Ph') chromosomes that arose through complex translocations that involv

Amplification of the BCR/ABL fusion gene

Amplification of the BCR/ABL fusion gene clustered on a masked Philadelphia chromosome in a patient with myeloblastic crisis of chronic myelocytic leukemia

✍ Patricia M. Gargallo; Maria Teresa Cuello; Pedro Negri Aranguren; Irene B. Larri 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Impact of BCR-ABL mutations on response

Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia

✍ Mario Tiribelli, Roberto Latagliata, Luigiana Luciano… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 143 KB

Velocity of early BCR-ABL transcript eli

Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib

✍ Hanfstein, B; Shlyakhto, V; Lauseker, M; Hehlmann, R; Saussele, S; Dietz, C; Erb 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 599 KB

Efficacy of imatinib dose escalation in

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

✍ Hagop M. Kantarjian; Richard A. Larson; Francois Guilhot; Stephen G. O'Brien; Ma 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB 👁 3 views